111 related articles for article (PubMed ID: 9270058)
1. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum.
Kelley JJ; Gao XM; Tamminga CA; Roberts RC
Exp Neurol; 1997 Aug; 146(2):471-8. PubMed ID: 9270058
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
3. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
4. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
Roberts RC; Force M; Kung L
Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rats: a study of unlabeled and enkephalin-labeled striatal terminals.
Roberts RC; Lapidus B
J Neural Transm (Vienna); 2003 Sep; 110(9):961-75. PubMed ID: 12938022
[TBL] [Abstract][Full Text] [Related]
7. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia.
Shoham S; Mazeh H; Javitt DC; Heresco-Levy U
Brain Res; 2004 Apr; 1004(1-2):142-7. PubMed ID: 15033429
[TBL] [Abstract][Full Text] [Related]
8. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration.
Andreassen OA; Meshul CK; Moore C; Jørgensen HA
Psychopharmacology (Berl); 2001 Aug; 157(1):11-9. PubMed ID: 11512038
[TBL] [Abstract][Full Text] [Related]
9. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Hamid EH; Hyde TM; Baca SM; Egan MF
Brain Res; 1998 Jun; 796(1-2):291-5. PubMed ID: 9689480
[TBL] [Abstract][Full Text] [Related]
10. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
Meshul CK; Andreassen OA; Allen C; Jørgensen HA
Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
[TBL] [Abstract][Full Text] [Related]
11. Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements.
Sasaki T; Kennedy JL; Nobrega JN
Synapse; 1997 Jan; 25(1):73-9. PubMed ID: 8987150
[TBL] [Abstract][Full Text] [Related]
12. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.
Meredith GE; De Souza IE; Hyde TM; Tipper G; Wong ML; Egan MF
J Neurosci; 2000 Oct; 20(20):7798-806. PubMed ID: 11027244
[TBL] [Abstract][Full Text] [Related]
13. Novel oral drug administration in an animal model of neuroleptic therapy.
Schleimer SB; Johnston GA; Henderson JM
J Neurosci Methods; 2005 Aug; 146(2):159-64. PubMed ID: 16054505
[TBL] [Abstract][Full Text] [Related]
14. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
Burger ME; Fachinetto R; Zeni G; Rocha JB
Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
[TBL] [Abstract][Full Text] [Related]
15. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.
Andreassen OA; Ferrante RJ; Beal MF; Jørgensen HA
Neuroscience; 1998 Dec; 87(3):639-48. PubMed ID: 9758230
[TBL] [Abstract][Full Text] [Related]
16. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
Kelley JJ; Roberts RC
J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
[TBL] [Abstract][Full Text] [Related]
17. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
18. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration.
Rodríguez JJ; Pickel VM
Synapse; 1999 Sep; 33(4):289-303. PubMed ID: 10421710
[TBL] [Abstract][Full Text] [Related]
20. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
